Virginia Regulatory Town Hall
Agency
Department of Health Professions
 
Board
Board of Medicine
 
chapter
Regulations Governing Prescribing of Opioids and Buprenorphine [18 VAC 85 ‑ 21]
Action Initial regulations
Stage Proposed
Comment Period Ended on 1/26/2018
spacer
Previous Comment     Next Comment     Back to List of Comments
1/22/18  11:45 am
Commenter: Mandy M. Atkinson, MD Pediatric Hematologist/Oncologist at Carilion

exception for sickle cell patients
 

I would also like the treatment of pain in patients with sickle cell disease to be an exception.  Many of these patients live with chronic pain with acute exacerbations they can manage at home.  Limitations on dosing would hinder their ability to do this and would send them to the ED, which typically would be either unnecessary or an overtreatment of something they could have handled at home.  Even managing children with sickle cell disease with these limitations is challenging.  I also think it is very important that patients with chronic pain know they have medicine when needed.

CommentID: 63380